These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 7901224)

  • 1. Differential heat stress stability of epidermal growth factor receptor and erbB-2 receptor tyrosine kinase activities.
    Liu SM; Carpenter G
    J Cell Physiol; 1993 Nov; 157(2):237-42. PubMed ID: 7901224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The carboxyl terminus of epidermal growth factor receptor/erbB-2 chimerae is internalization impaired.
    Sorkin A; Di Fiore PP; Carpenter G
    Oncogene; 1993 Nov; 8(11):3021-8. PubMed ID: 8105439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. erbB-2 autophosphorylation is required for mitogenic action and high-affinity substrate coupling.
    Segatto O; Lonardo F; Helin K; Wexler D; Fazioli F; Rhee SG; Di Fiore PP
    Oncogene; 1992 Jul; 7(7):1339-46. PubMed ID: 1352397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
    Donato NJ; Ince C; Rosenblum MG; Gallick GE
    J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cell dissociation and motility triggered by scatter factor/hepatocyte growth factor are mediated through the cytoplasmic domain of the c-Met receptor.
    Komada M; Kitamura N
    Oncogene; 1993 Sep; 8(9):2381-90. PubMed ID: 7689722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor, platelet-derived growth factor receptor, and c-erbB-2 receptor activation all promote growth but have distinctive effects upon mouse mammary epithelial cell differentiation.
    Taverna D; Groner B; Hynes NE
    Cell Growth Differ; 1991 Mar; 2(3):145-54. PubMed ID: 1676295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites.
    Soler C; Alvarez CV; Beguinot L; Carpenter G
    Oncogene; 1994 Aug; 9(8):2207-15. PubMed ID: 8036006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand.
    Lonardo F; Di Marco E; King CR; Pierce JH; Segatto O; Aaronson SA; Di Fiore PP
    New Biol; 1990 Nov; 2(11):992-1003. PubMed ID: 1983208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4.
    Komurasaki T; Toyoda H; Uchida D; Morimoto S
    Oncogene; 1997 Dec; 15(23):2841-8. PubMed ID: 9419975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
    Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
    EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of mammalian fibroblast transformation by normal and mutated human EGF receptors.
    Haley JD; Hsuan JJ; Waterfield MD
    Oncogene; 1989 Mar; 4(3):273-83. PubMed ID: 2784850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-independent tyrosine phosphorylation of EGF receptor and the erbB-2/neu proto-oncogene product is induced by hyperosmotic shock.
    King CR; Borrello I; Porter L; Comoglio P; Schlessinger J
    Oncogene; 1989 Jan; 4(1):13-8. PubMed ID: 2464783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
    Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
    J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
    Pinkas-Kramarski R; Lenferink AE; Bacus SS; Lyass L; van de Poll ML; Klapper LN; Tzahar E; Sela M; van Zoelen EJ; Yarden Y
    Oncogene; 1998 Mar; 16(10):1249-58. PubMed ID: 9546426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor.
    Chen WS; Lazar CS; Poenie M; Tsien RY; Gill GN; Rosenfeld MG
    Nature; 1987 Aug 27-Sep 2; 328(6133):820-3. PubMed ID: 3498122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the epidermal growth factor receptor associated with cytoskeletons of A431 cells.
    Roy LM; Gittinger CK; Landreth GE
    J Cell Physiol; 1989 Aug; 140(2):295-304. PubMed ID: 2745564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
    Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
    J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The erbB gene and the EGF receptor.
    Martin GS
    Cancer Surv; 1986; 5(2):199-219. PubMed ID: 2877733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor.
    Muthuswamy SK; Muller WJ
    Oncogene; 1995 Jul; 11(2):271-9. PubMed ID: 7542762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biological activity of the human epidermal growth factor receptor is positively regulated by its C-terminal tyrosines.
    Helin K; Velu T; Martin P; Vass WC; Allevato G; Lowy DR; Beguinot L
    Oncogene; 1991 May; 6(5):825-32. PubMed ID: 1646987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.